InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Sanofi

SNY Clue Score66
France Fiscal year ends December CIK 0001121404
$39.74 -0.82% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $39.74 −17.72% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2016Operating income6.53Net income4.71EPS, diluted3.63Fiscal year 2017Operating income5.80Net income8.42 +78.7%EPS, diluted6.64 +82.9%Fiscal year 2018Operating income4.68Net income4.31 −48.8%EPS, diluted3.43 −48.3%Fiscal year 2019Operating income3.05Net income2.75 −36.0%EPS, diluted2.23 −35.0%Fiscal year 2020Operating income14.11Net income12.29 +346.4%EPS, diluted9.77 +338.1%Fiscal year 2021Operating income8.13Net income6.22 −49.4%Fiscal year 2022Operating income10.16Net income8.37 +34.5%EPS, diluted6.66Fiscal year 2023Operating income6.96Net income5.40 −35.5%EPS, diluted4.30 −35.4%Fiscal year 2024Operating income7.25Net income5.56 +3.0%EPS, diluted4.43 +3.0%Fiscal year 2025Operating income6.34Net income7.81 +40.5%EPS, diluted6.37 +43.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating income 6.53 5.80 4.68 3.05 14.11 8.13 10.16 6.96 7.25 6.34
Net income 4.71 8.42 4.31 2.75 12.29 6.22 8.37 5.40 5.56 7.81
Growth +78.7% −48.8% −36.0% +346.4% −49.4% +34.5% −35.5% +3.0% +40.5%
EPS, diluted 3.63 6.64 3.43 2.23 9.77 n/a 6.66 4.30 4.43 6.37
Growth +82.9% −48.3% −35.0% +338.1% −35.4% +3.0% +43.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2016Operating cash flow7.84Buybacks−2.91Fiscal year 2017Operating cash flow7.38Buybacks−2.16Fiscal year 2018Operating cash flow5.55Buybacks−1.10Fiscal year 2019Operating cash flow7.72Buybacks−0.01Fiscal year 2020Operating cash flow7.42Buybacks−0.82Fiscal year 2021Operating cash flow10.52Buybacks−0.38Fiscal year 2022Operating cash flow10.53Buybacks−0.50Fiscal year 2023Operating cash flow10.26Buybacks−0.59Fiscal year 2024Operating cash flow9.08Buybacks−0.30Fiscal year 2025Operating cash flow10.75Buybacks−5.03
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 7.84 7.38 5.55 7.72 7.42 10.52 10.53 10.26 9.08 10.75
Buybacks −2.91 −2.16 −1.10 −0.01 −0.82 −0.38 −0.50 −0.59 −0.30 −5.03

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash10.27Total debt16.82Net cash (debt)−6.54Shareholders’ equity57.55Debt to equity0.29Fiscal year 2017Cash10.32Total debt14.33Net cash (debt)−4.01Shareholders’ equity58.07Debt to equity0.25Fiscal year 2018Cash6.93Total debt22.01Net cash (debt)−15.08Shareholders’ equity58.88Debt to equity0.37Fiscal year 2019Cash9.43Total debt20.13Net cash (debt)−10.70Shareholders’ equity59.06Debt to equity0.34Fiscal year 2020Cash13.92Total debt19.75Net cash (debt)−5.83Shareholders’ equity63.11Debt to equity0.31Fiscal year 2021Cash10.10Total debt17.12Net cash (debt)−7.03Shareholders’ equity68.68Debt to equity0.25Fiscal year 2022Cash12.74Total debt14.86Net cash (debt)−2.12Shareholders’ equity74.78Debt to equity0.20Fiscal year 2023Cash8.71Total debt14.35Net cash (debt)−5.64Shareholders’ equity74.04Debt to equity0.19Fiscal year 2024Cash7.44Total debt11.79Net cash (debt)−4.35Shareholders’ equity77.51Debt to equity0.15Fiscal year 2025Cash7.66Total debt14.25Net cash (debt)−6.59Shareholders’ equity71.38Debt to equity0.20
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 10.27 10.32 6.93 9.43 13.92 10.10 12.74 8.71 7.44 7.66
Total debt 16.82 14.33 22.01 20.13 19.75 17.12 14.86 14.35 11.79 14.25
Net cash (debt) −6.54 −4.01 −15.08 −10.70 −5.83 −7.03 −2.12 −5.64 −4.35 −6.59
Shareholders’ equity 57.55 58.07 58.88 59.06 63.11 68.68 74.78 74.04 77.51 71.38
Debt to equity 0.29 0.25 0.37 0.34 0.31 0.25 0.20 0.19 0.15 0.20

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
10.70 11.61 11.44 11.98 12.16 12.26 11.88 12.63 13.21 13.05
24.00 24.61 24.24 25.65 25.21 26.92 28.68 28.99 31.08 33.67
Growth +2.6% −1.5% +5.8% −1.7% +6.8% +6.5% +1.1% +7.2% +8.3%
5.17 5.47 5.89 6.02 5.53 5.69 6.50 6.51 7.39 7.84
9.48 10.07 9.86 9.88 9.39 9.56 8.74 8.93 9.18 9.54
6.53 5.80 4.68 3.05 14.11 8.13 10.16 6.96 7.25 6.34
Growth −11.1% −19.4% −34.8% +362.6% −42.4% +25.1% −31.5% +4.2% −12.5%
1.33 1.72 0.48 0.12 1.81 1.56 1.91 1.02 1.20 1.04
4.71 8.42 4.31 2.75 12.29 6.22 8.37 5.40 5.56 7.81
Growth +78.7% −48.8% −36.0% +346.4% −49.4% +34.5% −35.5% +3.0% +40.5%
Per share
3.66 6.70 3.45 2.24 9.82 n/a 6.69 4.31 4.44 6.40
3.63 6.64 3.43 2.23 9.77 n/a 6.66 4.30 4.43 6.37
Growth +82.9% −48.3% −35.0% +338.1% −35.4% +3.0% +43.8%
1,287 1,257 1,247 1,250 1,254 1,253 1,252 1,252 1,251 1,220
1,296 1,267 1,255 1,257 1,260 1,257 1,257 1,256 1,256 1,226
Growth −2.3% −0.9% +0.2% +0.2% −0.3% +0.0% −0.0% −0.0% −2.4%

Five years in brief

Worked out from the figures above, not from a press release
  • The diluted share count fell 2.7% in five years, so buybacks did some of the work per share.
  • Profitable in every one of the 10 years on file.